Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Lipid metabolism4743 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A17107 | 27988872 | Drugs | Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease. | 2017 | Details |
A17108 | 27988847 | Eur J Nutr | Calcium and vitamin D3 combinations improve fatty liver disease through AMPK-independent mechanisms. | 2016 | Details |
A17110 | 27986627 | Eur J Pharmacol | A novel and selective melanin-concentrating hormone receptor 1 antagonist ameliorates obesity and hepatic steatosis in diet-induced obese rodent models. | 2016 | Details |
A17120 | 27981809 | Mol Nutr Food Res | Chicoric acid attenuate a nonalcoholic steatohepatitis by inhibiting key regulators of lipid metabolism, fibrosis, oxidation, and inflammation in mice with methionine and choline deficiency. | 2017 | Details |
A17128 | 27976696 | Sci Rep | Phospholipase D1 deficiency in mice causes nonalcoholic fatty liver disease via an autophagy defect. | 2016 | Details |
A17141 | 27965104 | Genomics Proteomics Bioinformatics | Identification of Risk Pathways and Functional Modules for Coronary Artery Disease Based on Genome-wide SNP Data. | 2016 | Details |
A17144 | 27959408 | Mol Med Rep | Involvement of xanthine oxidase and paraoxonase 1 in the process of oxidative stress in nonalcoholic fatty liver disease. | 2016 | Details |
A17146 | 27957651 | Metab Brain Dis | Carnosic acid protects non-alcoholic fatty liver-induced dopaminergic neuron injury in rats. | 2016 | Details |
A17147 | 27957247 | World J Hepatol | Bibliometric analysis of top 100 cited articles in nonalcoholic fatty liver disease research. | 2016 | Details |
A17164 | 27938560 | Zhonghua Gan Zang Bing Za Zhi | [Effect of targeted inhibition of hypoxia-inducible factor-1α by 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole on the progression of non-alcoholic fatty liver disease in rats]. | 2016 | Details |
A17202 | 27916647 | Biochimie | PPARs and nonalcoholic fatty liver disease. | 2016 | Details |
A17215 | 27909723 | Mol Med Rep | Inhibition of JNK suppresses autophagy and attenuates insulin resistance in a rat model of nonalcoholic fatty liver disease. | 2016 | Details |
A17216 | 27908750 | Transl Res | Mesenchymal stromal cell-based therapies reduce obesity and metabolic syndromes induced by a high-fat diet. | 2016 | Details |
A17246 | 27890642 | Free Radic Biol Med | Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation. | 2016 | Details |
A17251 | 27889747 | Cell Physiol Biochem | Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells. | 2016 | Details |
A17269 | 27876064 | Lipids Health Dis | Melatonin improves non-alcoholic fatty liver disease via MAPK-JNK/P38 signaling in high-fat-diet-induced obese mice. | 2016 | Details |
A17276 | 27869139 | Sci Rep | The transcription cofactor CRTC1 protects from aberrant hepatic lipid accumulation. | 2016 | Details |
A17278 | 27866836 | Cell Metab | Physiological Suppression of Lipotoxic Liver Damage by Complementary Actions of HDAC3 and SCAP/SREBP. | 2016 | Details |
A17283 | 27863204 | Appl Physiol Nutr Metab | TNF and IL-18 cytokines may regulate liver fat storage under homeostasis conditions. | 2016 | Details |
A17286 | 27862769 | Cancer Sci | NS5ABP37 inhibits liver cancer by impeding lipogenesis and cholesterogenesis. | 2017 | Details |
A17297 | 27859493 | Clin Exp Pharmacol Physiol | Connexin32 deficiency is associated with liver injury, inflammation and oxidative stress in experimental non-alcoholic steatohepatitis. | 2017 | Details |
A17310 | 27855315 | J Nutr Biochem | Dietary sphingomyelin attenuates hepatic steatosis and adipose tissue inflammation in high-fat-diet-induced obese mice. | 2016 | Details |
A17311 | 27853276 | Sci Rep | SUMO-specific protease 3 is a key regulator for hepatic lipid metabolism in non-alcoholic fatty liver disease. | 2016 | Details |
A17321 | 27847552 | Oxid Med Cell Longev | Schisandrin B: A Double-Edged Sword in Nonalcoholic Fatty Liver Disease. | 2016 | Details |
A17336 | 27836672 | Biochem Pharmacol | Transcription factor binding site enrichment analysis predicts drivers of altered gene expression in nonalcoholic steatohepatitis. | 2016 | Details |
A17362 | 27824080 | Sci Rep | Lycium barbarum polysaccharide attenuates high-fat diet-induced hepatic steatosis by up-regulating SIRT1 expression and deacetylase activity. | 2016 | Details |
A17372 | 27821715 | Physiol Rep | A novel diet-induced murine model of steatohepatitis with fibrosis for screening and evaluation of drug candidates for nonalcoholic steatohepatitis. | 2016 | Details |
A17374 | 27818933 | Mol Metab | Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice. | 2016 | Details |
A17382 | 27813192 | Clin Exp Pharmacol Physiol | Naltrexone changes the expression of lipid metabolism-related proteins in the endoplasmic reticulum stress induced hepatic steatosis in mice. | 2017 | Details |
A17390 | 27504850 | J Clin Endocrinol Metab | Retinol-Binding Protein 4 Induces Hepatic Mitochondrial Dysfunction and Promotes Hepatic Steatosis. | 2016 | Details |
A17394 | 27780972 | Nat Rev Gastroenterol Hepatol | Developmental origins of NAFLD: a womb with a clue. | 2016 | Details |
A17395 | 27729660 | Nat Rev Gastroenterol Hepatol | NAFLD and diabetes mellitus. | 2016 | Details |
A17419 | 27794174 | Mol Nutr Food Res | Polyphenol-rich virgin olive oil reduces insulin resistance and liver inflammation and improves mitochondrial dysfunction in high-fat diet fed rats. | 2016 | Details |
A17423 | 27788733 | Zhonghua Gan Zang Bing Za Zhi | [Fine particulate matter and nonalcoholic fatty liver disease]. | 2016 | Details |
A17425 | 27788715 | Zhonghua Gan Zang Bing Za Zhi | [Autophagy and nonalcoholic fatty liver disease]. | 2016 | Details |
A17426 | 27788713 | Zhonghua Gan Zang Bing Za Zhi | [Cholesterol metabolism and non-alcoholic steatohepatitis]. | 2016 | Details |
A17431 | 27769711 | Chem Biol Interact | Esculetin prevents non-alcoholic fatty liver in diabetic mice fed high-fat diet. | 2016 | Details |
A17432 | 27710160 | Metab Syndr Relat Disord | Treatment of Nonalcoholic Fatty Liver Disease with Long-Chain n-3 Polyunsaturated Fatty Acids in Humans. | 2016 | Details |
A17438 | 27396601 | Curr Pharm Des | Lipids, Statins and Heart Failure: An Update. | 2016 | Details |
A17447 | 27193023 | Hepatol Int | Elevated hepatic lipid and interferon stimulated gene expression in HCV GT3 patients relative to non-alcoholic steatohepatitis. | 2016 | Details |
A17471 | 27773935 | Acta Pharmacol Sin | Alisol B 23-acetate protects against non-alcoholic steatohepatitis in mice via farnesoid X receptor activation. | 2016 | Details |
A17474 | 27732911 | J Nutr Biochem | Preventive effects of dietary walnuts on high-fat-induced hepatic fat accumulation, oxidative stress and apoptosis in mice. | 2016 | Details |
A17476 | 27693777 | Toxicol Lett | Myclobutanil worsens nonalcoholic fatty liver disease: An in vitro study of toxicity and apoptosis on HepG2 cells. | 2016 | Details |
A17485 | 27639843 | J Hepatol | Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review. | 2016 | Details |
A17488 | 27768909 | J Nutr Biochem | High-fructose corn syrup-55 consumption alters hepatic lipid metabolism and promotes triglyceride accumulation. | 2016 | Details |
A17491 | 27765690 | Gastroenterology | Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes. | 2016 | Details |
A17492 | 27765368 | Phytomedicine | The chloroform extract of Cyclocarya paliurus attenuates high-fat diet induced non-alcoholic hepatic steatosis in Sprague Dawley rats. | 2016 | Details |
A17494 | 27724997 | Br J Nutr | Rice endosperm protein slows progression of fatty liver and diabetic nephropathy in Zucker diabetic fatty rats. | 2016 | Details |
A17497 | 27637015 | Hepatology | Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice. | 2016 | Details |
A17512 | 27762456 | Phytother Res | Hovenia Dulcis Extract Reduces Lipid Accumulation in Oleic Acid-Induced Steatosis of Hep G2 Cells via Activation of AMPK and PPARα/CPT-1 Pathway and in Acute Hyperlipidemia Mouse Model. | 2016 | Details |
A17515 | 27761360 | FEBS Open Bio | Ezetimibe reduced hepatic steatosis induced by dietary oxysterols in nonhuman primates. | 2016 | Details |
A17518 | 27760195 | PLoS One | Prolyl Oligopeptidase Inhibition Attenuates Steatosis in the L02 Human Liver Cell Line. | 2016 | Details |
A17520 | 27759439 | Expert Opin Drug Metab Toxicol | Drug-induced steatohepatitis. | 2016 | Details |
A17524 | 27757845 | Protein Cell | Omic studies reveal the pathogenic lipid droplet proteins in non-alcoholic fatty liver disease. | 2016 | Details |
A17527 | 27738106 | J Biol Chem | Biliverdin Reductase A Attenuates Hepatic Steatosis by Inhibition of Glycogen Synthase Kinase (GSK) 3β Phosphorylation of Serine 73 of Peroxisome Proliferator-activated Receptor (PPAR) α. | 2016 | Details |
A17529 | 27658958 | J Mol Endocrinol | ERK-dependent mTOR pathway is involved in berberine-induced autophagy in hepatic steatosis. | 2016 | Details |
A17530 | 27639112 | Redox Biol | Effects of dietary fatty acids and cholesterol excess on liver injury: A lipidomic approach. | 2016 | Details |
A17557 | 27749006 | Mol Nutr Food Res | An extra virgin olive oil rich diet intervention ameliorates the nonalcoholic steatohepatitis induced by a high-fat "Western-type" diet in mice. | 2016 | Details |
A17586 | 27732787 | Annu Rev Med | Nonalcoholic Steatohepatitis. | 2016 | Details |
A17601 | 27723468 | J Nutr Biochem | Soy isoflavones (Glycine max) ameliorate hypertriglyceridemia and hepatic steatosis in high fat-fed ovariectomized Wistar rats (an experimental model of postmenopausal obesity). | 2016 | Details |
A17607 | 27720799 | Life Sci | Deletion of exons 3 and 4 in the mouse Nr1d1 gene worsens high-fat diet-induced hepatic steatosis. | 2016 | Details |
A17617 | 27713108 | Environ Health Perspect | Chronic Exposure to Low Doses of Dioxin Promotes Liver Fibrosis Development in the C57BL/6J Diet-Induced Obesity Mouse Model. | 2016 | Details |
A17625 | 27709009 | Acta Pharm Sin B | Fatty liver diseases, bile acids, and FXR. | 2016 | Details |
A17635 | 27697525 | Biochem Biophys Res Commun | Long-term fructose consumption prolongs hepatic stearoyl-CoA desaturase 1 activity independent of upstream regulation in rats. | 2016 | Details |
A17640 | 27694529 | Physiol Rep | Reduced mitochondrial mass and function add to age-related susceptibility toward diet-induced fatty liver in C57BL/6J mice. | 2016 | Details |
A17641 | 27693527 | Life Sci | Effect of HFD/STZ on expression of genes involved in lipid, cholesterol and glucose metabolism in rats. | 2016 | Details |
A17645 | 27692168 | Med Hypotheses | Does bilirubin prevent hepatic steatosis through activation of the PPARα nuclear receptor? | 2016 | Details |
A17651 | 27688653 | World J Gastroenterol | Iron and non-alcoholic fatty liver disease. | 2016 | Details |
A17657 | 29244927 | Patol Fiziol Eksp Ter | The impact of adipogenic diet on rats' tissue trace elements content. | 2018 | Details |
A17662 | 27680310 | Biochem Biophys Res Commun | Promiscuous activity of the LXR antagonist GSK2033 in a mouse model of fatty liver disease. | 2016 | Details |
A17663 | 27679530 | J Biol Chem | Perilipin-2 Deletion Impairs Hepatic Lipid Accumulation by Interfering with Sterol Regulatory Element-binding Protein (SREBP) Activation and Altering the Hepatic Lipidome. | 2016 | Details |
A17676 | 27669236 | Int J Mol Sci | miR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease. | 2016 | Details |
A17680 | 27663419 | J Hepatol | Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease. | 2016 | Details |
A17682 | 27660157 | Probiotics Antimicrob Proteins | Probiotics Supplemented with Omega-3 Fatty Acids are More Effective for Hepatic Steatosis Reduction in an Animal Model of Obesity. | 2017 | Details |
A17683 | 27660122 | Diabetes Care | Fatty Liver and Chronic Kidney Disease: Novel Mechanistic Insights and Therapeutic Opportunities. | 2016 | Details |
A17705 | 27642594 | Biomed Res Int | Lipid Regulation Effects of Raw and Processed Notoginseng Radix Et Rhizome on Steatotic Hepatocyte L02 Cell. | 2016 | Details |
A17730 | 27633111 | Adv Nutr | Improvements in Metabolic Health with Consumption of Ellagic Acid and Subsequent Conversion into Urolithins: Evidence and Mechanisms. | 2016 | Details |
A17731 | 27632923 | Nutr Res | Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα. | 2016 | Details |
A17733 | 27632189 | PLoS Comput Biol | A Computational Model of Hepatic Energy Metabolism: Understanding Zonated Damage and Steatosis in NAFLD. | 2016 | Details |
A17735 | 27631137 | Diabetologia | The suppression of hepatic glucose production improves metabolism and insulin sensitivity in subcutaneous adipose tissue in mice. | 2016 | Details |
A17736 | 27629750 | J Transl Med | Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease. | 2016 | Details |
A17737 | 27628945 | J Dig Dis | MicroRNAs as biomarkers and regulators of nonalcoholic fatty liver disease. | 2016 | Details |
A17742 | 27626926 | Cell Physiol Biochem | Differential Lipotoxic Effects of Palmitate and Oleate in Activated Human Hepatic Stellate Cells and Epithelial Hepatoma Cells. | 2016 | Details |
A17758 | 27616599 | Sci Rep | Relationship between grip strength and newly diagnosed nonalcoholic fatty liver disease in a large-scale adult population. | 2016 | Details |
A17764 | 27613825 | Physiol Rep | Treatment with didemnin B, an elongation factor 1A inhibitor, improves hepatic lipotoxicity in obese mice. | 2016 | Details |
A17768 | 27610012 | World J Gastroenterol | Metabolic aspects of adult patients with nonalcoholic fatty liver disease. | 2016 | Details |
A17771 | 27609031 | Exp Mol Med | MSP is a negative regulator of inflammation and lipogenesis in ex vivo models of non-alcoholic steatohepatitis. | 2016 | Details |
A17779 | 27600823 | Am J Physiol Endocrinol Metab | Aerobic capacity and hepatic mitochondrial lipid oxidation alters susceptibility for chronic high-fat diet-induced hepatic steatosis. | 2016 | Details |
A17786 | 27594563 | Postepy Hig Med Dosw (Online) | New peptides players in metabolic disorders. | 2016 | Details |
A17789 | 27592832 | Yakugaku Zasshi | Influence of High-fat and High-cholesterol Diet on Major CYP Activities in the Liver. | 2016 | Details |
A17803 | 27576208 | Surg Obes Relat Dis | PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery. | 2016 | Details |
A17825 | 27554471 | Diabetes | Salsalate (Salicylate) Uncouples Mitochondria, Improves Glucose Homeostasis, and Reduces Liver Lipids Independent of AMPK-β1. | 2016 | Details |
A17843 | 27542533 | Reprod Toxicol | Increased susceptibility of prenatal food restricted offspring to high-fat diet-induced nonalcoholic fatty liver disease is intrauterine programmed. | 2016 | Details |
A17866 | 27514483 | Am J Physiol Gastrointest Liver Physiol | Hepatocellular autophagy modulates the unfolded protein response and fasting-induced steatosis in mice. | 2016 | Details |
A17877 | 27506745 | Metabolism | Lipid phenotypes in patients with nonalcoholic fatty liver disease. | 2016 | Details |
A17889 | 27494683 | Int Immunopharmacol | High-fat diet plus carbon tetrachloride-induced liver fibrosis is alleviated by betaine treatment in rats. | 2016 | Details |
A17901 | 27487733 | Food Funct | Protective effects of glycyrrhizic acid from edible botanical glycyrrhiza glabra against non-alcoholic steatohepatitis in mice. | 2016 | Details |
A17905 | 27485440 | Nutr J | Role of bioactive fatty acids in nonalcoholic fatty liver disease. | 2016 | Details |
A17908 | 27484357 | Int J Food Sci Nutr | Mediterranean diet and nonalcoholic fatty liver disease: molecular mechanisms of protection. | 2016 | Details |
A17911 | 27483220 | Molecules | Efficacy of Acetylshikonin in Preventing Obesity and Hepatic Steatosis in db/db Mice. | 2016 | Details |